PULMONX CORPORATION (LUNG) Return on equity 2020–2025
PULMONX CORPORATION (LUNG) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-99.8%FY2025 · since FY2020: -14.3% → -99.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -99.8% | -34.1 pp |
| FY2024 | -65.7% | -14.3 pp |
| FY2023 | -51.4% | -13.2 pp |
| FY2022 | -38.3% | -13.1 pp |
| FY2021 | -25.2% | -10.9 pp |
| FY2020 | -14.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Net marginLUNG Gross profitLUNG Gross marginLUNG Operating incomeLUNG Operating marginLUNG Operating cash flowLUNG Free cash flowLUNG Capital expendituresLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →